The observation that knockdown of FUNDC2 also reduces expression of AFP, an indicator of HCC malignancy, and a marker of cancer stem cells, suggests that the cancer stem cell compartment may be more susceptible to inhibition of FUNDC2. The gene discussed is AFP; the disease is hepatocellular carcinoma.